Concepedia

Jing Wang

JW

249

Publications

31.2K

Citations

81

H-Index

1996

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Southwestern Medical Center

Baylor College of Medicine

Yale University

The University of Texas Health Science Center at Houston

Jing Wang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

Top concepts

MedicineCell BiologyTumor BiologyOncologyRadiation OncologyImmunologyCancer BiologyPathologyLung CancerCancer Research

Publications per year

1996–2025

249

Publications

249

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt et al. · Cancer Discovery · 2018 · 1.5K citations · Full text

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Spencer C. Wei, Jacob Levine, Alexandria P. Cogdill et al. · Cell · 2017 · 1.2K citations · Full text

Cancer Immunosurveillance, Immunology, Immune Checkpoint Inhibitor +4

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

Jing Lü, Yimin Qian, Martha Altieri et al. · Chemistry & Biology · 2015 · 1.1K citations · Full text

Natural Sciences, Molecular Biology, Dna Replication +3

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

Limo Chen, Don L. Gibbons, Sangeeta Goswami et al. · Nature Communications · 2014 · 970 citations · Full text

Intratumoral Immunosuppression, Microrna-200/zeb1 Axis Control, Medicine +9

Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead

Daniel P. Bondeson, Blake E. Smith, George M. Burslem et al. · Cell chemical biology · 2017 · 867 citations · Full text

Protac Design, Selective Degradation, Biomolecular Engineering +1

Rows per page

1–5 of 249